Literature DB >> 19574114

Beneficial effects and reversion of vascular lesions by thalidomide in a patient with bleeding portal hypertensive enteropathy.

M Jimenez-Saenz, J Romero-Vazquez, A Caunedo-Alvarez, B Maldonado-Perez, J M Herrerias Gutierrez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19574114     DOI： 10.1016/j.dld.2009.06.001

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN： 1590-8658            Impact factor:   4.088


× No keyword cloud information.
  5 in total

Review 1.  Non-variceal gastrointestinal bleeding in patients with liver cirrhosis: a review.

Authors:  M Kalafateli; C K Triantos; V Nikolopoulou; A Burroughs
Journal:  Dig Dis Sci       Date:  2012-06-04       Impact factor: 3.199

2.  Portal hypertensive enteropathy diagnosed by capsule endoscopy in cirrhotic patients: a nationwide multicenter study.

Authors:  Seong Ran Jeon; Jin-Oh Kim; Ji-Beom Kim; Byong Duk Ye; Dong Kyung Chang; Ki-Nam Shim; Dae Young Cheung; Jin Soo Kim; Myung Gyu Choi; Hyun Joo Song; Yun Jeong Lim; Soo Jung Park; Ji Hyun Kim; Jeong Seop Moon; Yoon Tae Jeen
Journal:  Dig Dis Sci       Date:  2014-02-04       Impact factor: 3.199

Review 3.  Emerging role of thalidomide in the treatment of gastrointestinal bleeding.

Authors:  Michael McFarlane; Lauren O'Flynn; Rachel Ventre; Benjamin R Disney
Journal:  Frontline Gastroenterol       Date:  2017-11-02

Review 4.  Capsule Endoscopy for Portal Hypertensive Enteropathy.

Authors:  Seong Ran Jeon; Jin-Oh Kim
Journal:  Gastroenterol Res Pract       Date:  2015-12-27       Impact factor: 2.260

5.  The Usefulness of New-Generation Capsule Endoscopy in Patients with Portal Hypertensive Enteropathy.

Authors:  Seung-Joo Nam; Ji Hyun Kim; Sung Chul Park
Journal:  Clin Endosc       Date:  2018-11-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.